18 followers
Randomized phase II dose comparison LITESPARK-013 study of belzutifan in patients with advanced clear cell renal cell carcinoma www.sciencedirect.com/science/arti...
Randomized phase II dose comparison LITESPARK-013 study of belzutifan in patients with advanced clear cell renal cell carcinoma ☆
Overview of attention for article published in Annals of Oncology, September 2024
Altmetric Badge
About this Attention Score
-
In the top 25% of all research outputs scored by Altmetric
-
High Attention Score compared to outputs of the same age (82nd percentile)
-
Good Attention Score compared to outputs of the same age and source (69th percentile)
Readers on
- mendeley
- 16 Mendeley